Cell TherapyS10LOL竞猜平台

LOL下注网站


S10LOL竞猜平台

S10LOL竞猜平台

 

The use of compounds as modulators of cells in the scientific area of regenerative medicine is an expanding field, therefore collaborating within this area of therapeutics, adds benefit to research and advances healthcare.

S10LOL竞猜平台

  • Sharing of small molecule compounds from our screening library
  • Potential access to specific antibody assets, depending upon the proposed target
  • Potential for further collaboration to advance your target

A key initiative at AstraZeneca is to share our compound libraries with academia and industry to advance the treatment of a broad range of diseases through regenerative medicine approaches, bringing the potential to cure patients that have an unmet medical need.

Johan Hyllner Senior Director, Head of Regeneration, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

LOL下注网站